US Patent Issued to Zevra Therapeutics on March 18 for "Gamma-hydroxybutyrate delivering compounds and processes for making and using them" (Virginia, Iowa, Florida Inventors)

ALEXANDRIA, Va., March 19 -- United States Patent no. 12,251,445, issued on March 18, was assigned to Zevra Therapeutics Inc..

"Gamma-hydroxybutyrate delivering compounds and processes for making and using them" was invented by Sanjib Bera (Blacksburg, Va.), Sven Guenther (Coralville, Iowa), Adam Smith (Orlando, Fla.) and Travis Mickle (Kissimmee, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are one or more compounds comprising chemically modified gamma-hydroxybutyrate (GHB), 2-hydroxytetrahydrofuran, and/or 1,4-butanediol, and salts of such compounds (GHB delivering compounds and salts thereof). Also disclosed are compositions comprising at least one GHB delivering compound, or a salt there...